References
- Hellmich B, Agueda A, Monti S, Buttgereit F, De Boysson H, Brouwer E, et al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2020;79:19–30.
- Yachoui R, Kreidy M, Siorek M, Sehgal R. Successful treatment with ustekinumab for corticosteroid- and immunosuppressant-resistant Takayasu’s arteritis. Scand J Rheumatol 2018;47:246–7.
- Kuwabara S, Tanimura S, Matsumoto S, Nakamura H, Horita T. Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis. Ann Rheum Dis 2020;79:1125–6.
- Rios Rodriguez V, Rademacher J, Protopopov M, Torgutalp M, Haibel H, Vahldiek JL, et al. Comment on: ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis’ by Kuwabara et al. Ann Rheum Dis 2020 June 24. Epub ahead of print.
- Li J, Li M, Tian X, Zeng X. Tofacitinib in patients with refractory Takayasu’s arteritis. Rheumatology (Oxford) 2020;59:e95–e98.
- Sato S, Matsumoto H, Temmoku J, Fujita Y, Matsuoka N, Furuya M, et al. A case of Takayasu arteritis complicated by refractory ulcerative colitis successfully treated with tofacitinib. Rheumatology (Oxford) 2020;59:1773–5.
- Yamamura Y, Matsumoto Y, Asano Y, Katayama Y, Hayashi K, Ohashi K, et al. Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib. Rheumatol Adv Pract 2020;4:rkz050.
- Usui J, Takemura H, Yuhara T, Akama T, Suzuki H, Yamane K, et al. Dieulafoy’s lesion of the esophagus as a probable complication of Takayasu’s arteritis. J Rheumatol 1999;26:454–6.
- Palermo A, Marvisi C, Casali M, Pipitone N, Muratore F, Salvarani C. Tofacitinib for the treatment of refractory Takayasu’s arteritis: description of 2 cases. Clin Exp Rheumatol 2020;38:234–5.
- Lamba M, Wang R, Fletcher T, Alvey C, Kushner J 4th, Stock TC. Extended-release once-daily formulation of tofacitinib: evaluation of pharmacokinetics compared with immediate-release tofacitinib and impact of food. J Clin Pharmacol 2016;56:1362–71.